Ogun State Confirms Lassa Fever Outbreak Reports Fatality
Ogun State Confirms Lassa Fever Outbreak Reports Fatality
Ogun State’s Commissioner for Health, Dr. Tomi Coker, has confirmed an outbreak of Lassa Fever in the state, which has resulted in a fatality. The victim, a 25-year-old female National Youth Service Corps (NYSC) member, fell ill while in Ondo State and was subsequently transferred to a secondary health facility in Ijebu North Local Government Area of Ogun, where she passed away on March 18, 2025.
In a statement issued on Wednesday in Abeokuta, Dr. Coker outlined the symptoms of Lassa Fever, which include high fever, headache, body weakness, sore throat, muscle pain, cough, nausea, vomiting, diarrhea, chest pain, and unexplained bleeding from various body openings, such as the eyes, ears, nose, and mouth.
Dr. Coker urged the public to report any individuals exhibiting these symptoms to the nearest government health facility for immediate medical attention. She emphasized the importance of early detection and intervention, advising that any case of febrile illness not responding to treatment with anti-malarial drugs or antibiotics within 48 hours should raise concerns about possible Lassa Fever infection….READ MORE…
The commissioner also called on both public and private health facilities in Ogun State to reinforce infection prevention and control protocols, ensuring compliance among healthcare staff. Health workers are encouraged to consult with local disease surveillance officers or the state’s Disease Surveillance and Notification Officer in the event of suspected cases.
In response to the outbreak, the Ogun State Ministry of Health, in collaboration with the Rapid Response Team in Ijebu North East, is closely monitoring the situation with enhanced surveillance and community outreach to ensure a prompt and effective response.
Dr. Coker reassured residents that the Ogun State Government is committed to safeguarding public health through continuous monitoring and swift action against infectious diseases.

Comments
0 comments